Skip to main content
Judy M Cheng, M.D., PhD

Judy M Cheng, M.D., PhD

Investigator

Judy Mary Cheng, MD, PhD is a board-certified medical oncologist and hematologist with Palo Alto Foundation Medical Group in San Mateo, California. She earned her BS with High Distinction in Cellular and Molecular Biology from the University of Michigan and completed her MD/PhD in Molecular Genetics at Washington University School of Medicine. Dr. Cheng completed her internal medicine residency at the Hospital of the University of Pennsylvania and a fellowship in Hematology/Oncology at the University of California, San Francisco (UCSF). She has served on the UCSF faculty for more than two decades, achieving the rank of Clinical Professor of Medicine, and previously directed the Oncology Clinic at Zuckerberg San Francisco General Hospital. Her clinical and research interests include breast cancer, hematologic malignancies, and improving access to clinical trials. Dr. Cheng is actively involved in oncology clinical research, medical education, and mentoring trainees.

Clinical trials

  • A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?